Jump to content

User talk:Onc1975

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Welcome!

[edit]

Welcome...

Welcome!

Hello, Onc1975, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful:

Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Questions, ask me on my talk page, or place {{helpme}} on your talk page and ask your question there.

I have also replied to your post at the New contributors' help page.

Again, welcome! —Elipongo (Talk contribs) 14:14, 23 July 2007 (UTC)[reply]

Notice

The article FDA Special Protocol Assessment has been proposed for deletion because of the following concern:

WP:PRIMARY, seems to be a non-notable division

While all constructive contributions to Wikipedia are appreciated, pages may be deleted for any of several reasons.

You may prevent the proposed deletion by removing the {{proposed deletion/dated}} notice, but please explain why in your edit summary or on the article's talk page.

Please consider improving the page to address the issues raised. Removing {{proposed deletion/dated}} will stop the proposed deletion process, but other deletion processes exist. In particular, the speedy deletion process can result in deletion without discussion, and articles for deletion allows discussion to reach consensus for deletion.

This bot DID NOT nominate any of your contributions for deletion; please refer to the history of each individual page for details. Thanks, FastilyBot (talk) 10:00, 7 January 2022 (UTC)[reply]

Nomination of FDA Special Protocol Assessment for deletion

[edit]
A discussion is taking place as to whether the article FDA Special Protocol Assessment is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Wikipedia:Articles for deletion/FDA Special Protocol Assessment until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.

RockstoneSend me a message! 00:09, 12 January 2022 (UTC)[reply]